The world's scientific and social network for malaria professionals
Subscribe to free Newsletter | 10168 malaria professionals are enjoying the free benefits of MalariaWorld today

malERA Refresh update

April 22, 2016 - 08:30 -- MESA Alliance

On April 11, the chairs, co-chairs and rapporteurs from the six panels of ‘malERA Refresh’ met in Barcelona to share the main challenges and exciting research opportunities identified in their different thematic panels. 

  • Basic science and enabling technologies
  • Insecticide and drug resistance
  • Characterizing the reservoir and measuring transmission
  • Tools for elimination
  • Combining interventions and modelling
  • Health systems and policy research

The participants concluded that the new ‘malERA Refresh’ research agenda needs to encourage scientific curiosity and exploration. Experts from other fields need to be inspired to think about problem solving in malaria. There are more possibilities now than in 2011 when the malERA research agenda was first published, and new gene editing technologies such as CRISPR can help unlock the secrets of both parasite and vector genomes.

The six malERA Refresh Panels are now refining their papers with the aim of submitting them for publication in an open access journal this year. 

What is malERA Refresh?
Last year, the Malaria Eradication Scientific Alliance (MESA) launched a consultative process with the community to evaluate the scientific progress achieved and update the malaria eradication research agenda.

Six thematic panels composed of 150 worldwide experts from academia, industry, endemic countries, WHO and funding organisations are examining progress, gaps and opportunities for science to advance progress towards malaria elimination and eradication. Details of the Panels and the experts involved can be found on the MESA website.

The initiative is led by Regina Rabinovich (ISGlobal/Harvard T.H. Chan School of Public Health), Dyann Wirth (Harvard T.H. Chan School of Public Health), Marcel Tanner (Swiss TPH) and Pedro Alonso (WHO GMP).